Atopic dermatitis

The Lancet

Volumn 387, Issue 10023, 2016, Pages 1109-1122

  Weidinger, Stephan ^a   Novak, Natalija ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CALCINEURIN INHIBITOR; CORTICOSTEROID; EMOLLIENT AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; DERMATOLOGICAL AGENT;

ATOPIC DERMATITIS; CLINICAL FEATURE; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DISEASE COURSE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION COMPLICATION; KAPOSI VARICELLIFORM ERUPTION; META ANALYSIS (TOPIC); MOLLUSCUM CONTAGIOSUM; MULTICENTER STUDY (TOPIC); NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 4 CLINICAL TRIAL (TOPIC); PHOTOTHERAPY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SKIN PROTECTION; SOCIETY; SYSTEMATIC REVIEW (TOPIC); ADULT; CHILD; COST OF ILLNESS; DERMATITIS, ATOPIC; HEALTH; INFANT; PATHOLOGY;

ADULT; CHILD; COST OF ILLNESS; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; GLOBAL HEALTH; HUMANS; INFANT; PREVALENCE; RISK FACTORS;

EID: 84961201650     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00149-X     Document Type: Conference Paper

References (157)

1. D Wallach, A Taïeb Atopic dermatitis/atopic eczema Chem Immunol Allergy 100 2014 81 96
2. H Williams, C Flohr How epidemiology has challenged 3 prevailing concepts about atopic dermatitis J Allergy Clin Immunol 118 2006 209 213
3. PM Elias, M Steinhoff "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis J Invest Dermatol 128 2008 1067 1070
4. IA Deckers, S McLean, S Linssen, M Mommers, CP van Schayck, A Sheikh Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies PLoS One 7 2012 e39803
5. H Williams, A Stewart, E von Mutius, W Cookson, HR Anderson the International Study of Asthma and Allergies in Childhood (ISAAC) Phase One and Three Study Groups Is eczema really on the increase worldwide? J Allergy Clin Immunol 121 2008 947 954 e15.
6. S Illi, E von Mutius, S Lau the Multicenter Allergy Study Group The natural course of atopic dermatitis from birth to age 7 years and the association with asthma J Allergy Clin Immunol 113 2004 925 931
7. D Garmhausen, T Hagemann, T Bieber et al. Characterization of different courses of atopic dermatitis in adolescent and adult patients Allergy 68 2013 498 506
8. N Ballardini, I Kull, C Söderhäll, G Lilja, M Wickman, CF Wahlgren Eczema severity in preadolescent children and its relation to sex, filaggrin mutations, asthma, rhinitis, aggravating factors and topical treatment: a report from the BAMSE birth cohort Br J Dermatol 168 2013 588 594
9. AS Peters, J Kellberger, C Vogelberg et al. Prediction of the incidence, recurrence, and persistence of atopic dermatitis in adolescence: a prospective cohort study J Allergy Clin Immunol 126 2010 590 595 e1-3.
10. JI Silverberg, JM Hanifin Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study J Allergy Clin Immunol 132 2013 1132 1138
11. JS Margolis, K Abuabara, W Bilker, O Hoffstad, DJ Margolis Persistence of mild to moderate atopic dermatitis JAMA Dermatol 150 2014 593 600
12. EE Brenninkmeijer, ME Schram, MM Leeflang, JD Bos, PI Spuls Diagnostic criteria for atopic dermatitis: a systematic review Br J Dermatol 158 2008 754 765
13. J Schmitt, C Apfelbacher, PI Spuls et al. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology J Invest Dermatol 135 2015 24 30
14. J Schmitt, S Langan, HC Williams the European Dermato-Epidemiology Network What are the best outcome measurements for atopic eczema? A systematic review J Allergy Clin Immunol 120 2007 1389 1398
15. FM de Benedictis, F Franceschini, D Hill the EPAAC Study Group The allergic sensitization in infants with atopic eczema from different countries Allergy 64 2009 295 303
16. G Longo, I Berti, AW Burks, B Krauss, E Barbi IgE-mediated food allergy in children Lancet 382 2013 1656 1664
17. E Eller, HF Kjaer, A Høst, KE Andersen, C Bindslev-Jensen Food allergy and food sensitization in early childhood: results from the DARC cohort Allergy 64 2009 1023 1029
18. M Worm, K Forschner, HH Lee et al. Frequency of atopic dermatitis and relevance of food allergy in adults in Germany Acta Derm Venereol 86 2006 119 122
19. PE Martin, JK Eckert, JJ Koplin the HealthNuts Study Investigators Which infants with eczema are at risk of food allergy? Results from a population-based cohort Clin Exp Allergy 45 2015 255 264
20. JA Wisniewski, R Agrawal, S Minnicozzi et al. Sensitization to food and inhalant allergens in relation to age and wheeze among children with atopic dermatitis Clin Exp Allergy 43 2013 1160 1170
21. A Sonesson, J Bartosik, J Christiansen et al. Sensitization to skin-associated microorganisms in adult patients with atopic dermatitis is of importance for disease severity Acta Derm Venereol 93 2013 340 345
22. J Oh, S Conlan, EC Polley, JA Segre, HH Kong Shifts in human skin and nares microbiota of healthy children and adults Genome Med 4 2012 77
23. HH Kong, J Oh, C Deming the NISC Comparative Sequence Program Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis Genome Res 22 2012 850 859
24. LA Beck, M Boguniewicz, T Hata et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum J Allergy Clin Immunol 124 2009 260 269 e7.
25. X Chen, AV Anstey, JJ Bugert Molluscum contagiosum virus infection Lancet Infect Dis 13 2013 877 888
26. K Darabi, SG Hostetler, MA Bechtel, M Zirwas The role of Malassezia in atopic dermatitis affecting the head and neck of adults J Am Acad Dermatol 60 2009 125 136
27. G Heine, A Schnuch, W Uter, M Worm the Information Network of Departments of Dermatology (IVDK) the German Contact Dermatitis Research Group (DKG) Type-IV sensitization profile of individuals with atopic eczema: results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG) Allergy 61 2006 611 616
28. PE Beattie, MS Lewis-Jones A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases Br J Dermatol 155 2006 145 151
29. J Schmitt, A Buske-Kirschbaum, V Roessner Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review Allergy 65 2010 1506 1524
30. P Yaghmaie, CW Koudelka, EL Simpson Mental health comorbidity in patients with atopic dermatitis J Allergy Clin Immunol 131 2013 428 433
31. FJ Dalgard, U Gieler, L Tomas-Aragones et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries J Invest Dermatol 135 2015 984 991
32. AE van der Hulst, H Klip, PL Brand Risk of developing asthma in young children with atopic eczema: a systematic review J Allergy Clin Immunol 120 2007 565 569
33. DC Belgrave, R Granell, A Simpson et al. Developmental profiles of eczema, wheeze, and rhinitis: two population-based birth cohort studies PLoS Med 11 2014 e1001748
34. M Pinart, M Benet, I Annesi-Maesano et al. Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study Lancet Respir Med 2 2014 131 140
35. J Schmitt, K Schwarz, H Baurecht et al. Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type-1 diabetes J Allergy Clin Immunol 2015 10.1016/j.jaci.2015.06.029 published online Aug 4.
36. GC Mohan, JI Silverberg Association of vitiligo and alopecia areata with atopic dermatitis: a systematic review and meta-analysis JAMA Dermatol 151 2015 522 528
37. S Deckert, C Kopkow, J Schmitt Nonallergic comorbidities of atopic eczema: an overview of systematic reviews Allergy 69 2014 37 45
38. CJ Murray, T Vos, R Lozano et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2197 2223
39. T Vos, AD Flaxman, M Naghavi et al. years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2163 2196
40. AJ Mancini, K Kaulback, SL Chamlin The socioeconomic impact of atopic dermatitis in the United States: a systematic review Pediatr Dermatol 25 2008 1 6
41. G Ricci, B Bendandi, L Pagliara, A Patrizi, M Masi Atopic dermatitis in Italian children: evaluation of its economic impact J Pediatr Health Care 20 2006 311 315
42. DC Suh, J Sung, D Gause, M Raut, J Huang, IS Choi Economic burden of atopic manifestations in patients with atopic dermatitis - analysis of administrative claims J Manag Care Pharm 13 2007 778 789
43. CJ Apfelbacher, TL Diepgen, J Schmitt Determinants of eczema: population-based cross-sectional study in Germany Allergy 66 2011 206 213
44. SF Thomsen, CS Ulrik, KO Kyvik et al. Importance of genetic factors in the etiology of atopic dermatitis: a twin study Allergy Asthma Proc 28 2007 535 539
45. D Ellinghaus, H Baurecht, J Esparza-Gordillo et al. High-density genotyping study identifies four new susceptibility loci for atopic dermatitis Nat Genet 45 2013 808 812
46. J Esparza-Gordillo, S Weidinger, R Fölster-Holst et al. A common variant on chromosome 11q13 is associated with atopic dermatitis Nat Genet 41 2009 596 601
47. L Paternoster, M Standl, CM Chen the Australian Asthma Genetics Consortium (AAGC) the Genetics of Overweight Young Adults (GOYA) Consortium the EArly Genetics & Lifecourse Epidemiology (EAGLE) Consortium Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis Nat Genet 44 2012 187 192
48. LD Sun, FL Xiao, Y Li et al. Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population Nat Genet 43 2011 690 694
49. T Hirota, A Takahashi, M Kubo et al. Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population Nat Genet 44 2012 1222 1226
50. Paternoster L, Standl M, Waage J, et al. Multi-ethnic genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat Genet (in press).
51. AD Irvine, WH McLean, DY Leung Filaggrin mutations associated with skin and allergic diseases N Engl J Med 365 2011 1315 1327
52. C Flohr, J Mann New insights into the epidemiology of childhood atopic dermatitis Allergy 69 2014 3 16
53. C Flohr, L Yeo Atopic dermatitis and the hygiene hypothesis revisited Curr Probl Dermatol 41 2011 1 34
54. S Kezic, N Novak, I Jakasa et al. Skin barrier in atopic dermatitis Front Biosci 19 2014 542 556
55. C Flohr, K England, S Radulovic et al. Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age Br J Dermatol 163 2010 1333 1336
56. JM Jungersted, H Scheer, M Mempel et al. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema Allergy 65 2010 911 918
57. J Ishikawa, H Narita, N Kondo et al. Changes in the ceramide profile of atopic dermatitis patients J Invest Dermatol 130 2010 2511 2514
58. M Janssens, J van Smeden, GS Gooris et al. Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients J Lipid Res 53 2012 2755 2766
59. R Voegeli, AV Rawlings, M Breternitz, S Doppler, T Schreier, JW Fluhr Increased stratum corneum serine protease activity in acute eczematous atopic skin Br J Dermatol 161 2009 70 77
60. L Samuelov, E Sprecher Peeling off the genetics of atopic dermatitis-like congenital disorders J Allergy Clin Immunol 134 2014 808 815
61. JP Thyssen, S Kezic Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis J Allergy Clin Immunol 134 2014 792 799
62. V Pendaries, J Malaisse, L Pellerin et al. Knockdown of filaggrin in a three-dimensional reconstructed human epidermis impairs keratinocyte differentiation J Invest Dermatol 134 2014 2938 2946
63. R Gruber, PM Elias, D Crumrine et al. Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function Am J Pathol 178 2011 2252 2263
64. K Vávrová, D Henkes, K Strüver et al. Filaggrin deficiency leads to impaired lipid profile and altered acidification pathways in a 3D skin construct J Invest Dermatol 134 2014 746 753
65. PS Gao, NM Rafaels, T Hand et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum J Allergy Clin Immunol 124 2009 507 513 e7.
66. H Miajlovic, PG Fallon, AD Irvine, TJ Foster Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus J Allergy Clin Immunol 126 2010 1184 1190 e3.
67. TC Scharschmidt, MQ Man, Y Hatano et al. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens J Allergy Clin Immunol 124 2009 496 506 e6.
68. H Kawasaki, K Nagao, A Kubo et al. Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice J Allergy Clin Immunol 129 2012 1538 1546 e6.
69. S Kezic, GM O'Regan, R Lutter et al. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency J Allergy Clin Immunol 129 2012 1031 1039 e1.
70. M Mildner, J Jin, L Eckhart et al. Knockdown of filaggrin impairs diffusion barrier function and increases UV sensitivity in a human skin model J Invest Dermatol 130 2010 2286 2294
71. PG Fallon, T Sasaki, A Sandilands et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming Nat Genet 41 2009 602 608
72. M Suarez-Farinas, SJ Tintle, A Shemer et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities J Allergy Clin Immunol 127 2011 954 964 e4.
73. SA Islam, AD Luster T cell homing to epithelial barriers in allergic disease Nat Med 18 2012 705 715
74. Y Imai, K Yasuda, Y Sakaguchi et al. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice Proc Natl Acad Sci USA 110 2013 13921 13926
75. M Salimi, JL Barlow, SP Saunders et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis J Exp Med 210 2013 2939 2950
76. M Tominaga, K Takamori Itch and nerve fibers with special reference to atopic dermatitis: therapeutic implications J Dermatol 41 2014 205 212
77. S Stutte, T Quast, N Gerbitzki et al. Requirement of CCL17 for CCR7- and CXCR4-dependent migration of cutaneous dendritic cells Proc Natl Acad Sci USA 107 2010 8736 8741
78. H22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis J Allergy Clin Immunol 130 2012 1344 1354
79. KE Nograles, LC Zaba, A Shemer et al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells J Allergy Clin Immunol 123 2009 1244 1252 e2.
80. SF Ziegler Thymic stromal lymphopoietin and allergic disease J Allergy Clin Immunol 130 2012 845 852
81. S Eyerich, K Eyerich, D Pennino et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling J Clin Invest 119 2009 3573 3585
82. D Simon, C Aeberhard, Y Erdemoglu, HU Simon Th17 cells and tissue remodeling in atopic and contact dermatitis Allergy 69 2014 125 131
83. JM Leyva-Castillo, P Hener, P Michea et al. Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade Nat Commun 4 2013 2847
84. S Khattri, A Shemer, M Rozenblit et al. Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology J Allergy Clin Immunol 133 2014 1626 1634
85. N Novak An update on the role of human dendritic cells in patients with atopic dermatitis J Allergy Clin Immunol 129 2012 879 886
86. S Zeller, C Rhyner, N Meyer, P Schmid-Grendelmeier, CA Akdis, R Crameri Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema J Allergy Clin Immunol 124 2009 278 285 e7.
87. TS Tang, T Bieber, HC Williams Does "autoreactivity" play a role in atopic dermatitis? J Allergy Clin Immunol 129 2012 1209 1215 e2.
88. A Heratizadeh, I Mittermann, H Balaji et al. The role of T-cell reactivity towards the autoantigen α-NAC in atopic dermatitis Br J Dermatol 164 2011 316 324
89. H Balaji, A Heratizadeh, K Wichmann et al. Malassezia sympodialis thioredoxin-specific T cells are highly cross-reactive to human thioredoxin in atopic dermatitis J Allergy Clin Immunol 128 2011 92 99 e4.
90. B Homey, M Steinhoff, T Ruzicka, DY Leung Cytokines and chemokines orchestrate atopic skin inflammation J Allergy Clin Immunol 118 2006 178 189
91. M Hvid, C Vestergaard, K Kemp, GB Christensen, B Deleuran, M Deleuran IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction? J Invest Dermatol 131 2011 150 157
92. T Savinko, S Matikainen, U Saarialho-Kere et al. IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors J Invest Dermatol 132 2012 1392 1400
93. H2 response by inducing cutaneous thymic stromal lymphopoietin expression J Allergy Clin Immunol 126 2010 976 984 e5.
94. HA Brough, AH Liu, S Sicherer et al. Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy J Allergy Clin Immunol 135 2015 164 170
95. LM Bartnikas, MF Gurish, OT Burton et al. Epicutaneous sensitization results in IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis J Allergy Clin Immunol 131 2013 451 460 e6.
96. V Kopfnagel, J Harder, T Werfel Expression of antimicrobial peptides in atopic dermatitis and possible immunoregulatory functions Curr Opin Allergy Clin Immunol 13 2013 531 536
97. V van Drongelen, EM Haisma, JJ Out-Luiting, PH Nibbering, A El Ghalbzouri Reduced filaggrin expression is accompanied by increased Staphylococcus aureus colonization of epidermal skin models Clin Exp Allergy 44 2014 1515 1524
98. Y Hirasawa, T Takai, T Nakamura et al. Staphylococcus aureus extracellular protease causes epidermal barrier dysfunction J Invest Dermatol 130 2010 614 617
99. O Takeuchi, S Akira Pattern recognition receptors and inflammation Cell 140 2010 805 820
100. MB Ganem, MC De Marzi, MJ Fernández-Lynch et al. Uptake and intracellular trafficking of superantigens in dendritic cells PLoS One 8 2013 e66244
101. Y Nakamura, J Oscherwitz, KB Cease et al. Staphylococcus δ-toxin induces allergic skin disease by activating mast cells Nature 503 2013 397 401
102. L Bin, MG Edwards, R Heiser et al. Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum J Allergy Clin Immunol 134 2014 848 855
103. DY Leung, PS Gao, DN Grigoryev et al. Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response J Allergy Clin Immunol 127 2011 965 973 e5.
104. C Cornelissen, Y Marquardt, K Czaja et al. IL-31 regulates differentiation and filaggrin expression in human organotypic skin models J Allergy Clin Immunol 129 2012 426 433 e8.
105. DI Batista, L Perez, RL Orfali et al. Profile of skin barrier proteins (filaggrin, claudins 1 and 4) and Th1/Th2/Th17 cytokines in adults with atopic dermatitis J Eur Acad Dermatol Venereol 29 2015 1091 1095
106. M Omori-Miyake, M Yamashita, Y Tsunemi, M Kawashima, J Yagi In vitro assessment of IL-4- or IL-13-mediated changes in the structural components of keratinocytes in mice and humans J Invest Dermatol 134 2014 1342 1350
107. A De Benedetto, NM Rafaels, LY McGirt et al. Tight junction defects in patients with atopic dermatitis J Allergy Clin Immunol 127 2011 773 786 e7.
108. S Morizane, K Yamasaki, A Kajita et al. TH2 cytokines increase kallikrein 7 expression and function in patients with atopic dermatitis J Allergy Clin Immunol 130 2012 259 261 e1.
109. MO Danso, V van Drongelen, A Mulder et al. TNF-α and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents J Invest Dermatol 134 2014 1941 1950
110. J Buddenkotte, M Steinhoff Pathophysiology and therapy of pruritus in allergic and atopic diseases Allergy 65 2010 805 821
111. MH Oh, SY Oh, J Lu et al. TRPA1-dependent pruritus in IL-13-induced chronic atopic dermatitis J Immunol 191 2013 5371 5382
112. F Cevikbas, X Wang, T Akiyama et al. A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: involvement of TRPV1 and TRPA1 J Allergy Clin Immunol 133 2014 448 460
113. D Roggenkamp, S Köpnick, F Stäb, H Wenck, M Schmelz, G Neufang Epidermal nerve fibers modulate keratinocyte growth via neuropeptide signaling in an innervated skin model J Invest Dermatol 133 2013 1620 1628
114. H Aubert-Wastiaux, L Moret, A Le Rhun et al. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency Br J Dermatol 165 2011 808 814
115. SJ Ersser, F Cowdell, S Latter et al. Psychological and educational interventions for atopic eczema in children Cochrane Database Syst Rev 1 2014 CD004054
116. JP Ng, HM Liew, SB Ang Use of emollients in atopic dermatitis J Eur Acad Dermatol Venereol 29 2015 854 857
117. SM Langan, P Silcocks, HC Williams What causes flares of eczema in children? Br J Dermatol 161 2009 640 646
118. SM Langan, HC Williams What causes worsening of eczema? A systematic review Br J Dermatol 155 2006 504 514
119. SM Langan, C Flohr, HC Williams The role of furry pets in eczema: a systematic review Arch Dermatol 143 2007 1570 1577
120. H Nankervis, EV Pynn, RJ Boyle et al. House dust mite reduction and avoidance measures for treating eczema Cochrane Database Syst Rev 1 2015 CD008426
121. F Bath-Hextall, FM Delamere, HC Williams Dietary exclusions for improving established atopic eczema in adults and children: systematic review Allergy 64 2009 258 264
122. C Hoare, A Li Wan Po, H Williams Systematic review of treatments for atopic eczema Health Technol Assess 4 2000 1 191
123. E Castela, E Archier, S Devaux et al. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy J Eur Acad Dermatol Venereol 26 suppl 3 2012 47 51
124. C Green, JL Colquitt, J Kirby, P Davidson, E Payne Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation Health Technol Assess 8 2004 iii, iv, 1-120.
125. SR Janmohamed, AP Oranje, AC Devillers et al. The proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled trial J Am Acad Dermatol 70 2014 1076 1082
126. DM Ashcroft, P Dimmock, R Garside, K Stein, HC Williams Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials BMJ 330 2005 516
127. SL Chen, J Yan, FS Wang Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials J Dermatolog Treat 21 2010 144 156
128. R Aschoff, J Schmitt, P Knuschke, E Koch, M Bräutigam, M Meurer Evaluation of the atrophogenic potential of hydrocortisone 1% cream and pimecrolimus 1% cream in uninvolved forehead skin of patients with atopic dermatitis using optical coherence tomography Exp Dermatol 20 2011 832 836
129. IL Shlivko, VA Kamensky, EV Donchenko, P Agrba Morphological changes in skin of different phototypes under the action of topical corticosteroid therapy and tacrolimus Skin Res Technol 20 2014 136 140
130. B Sigurgeirsson, A Boznanski, G Todd et al. Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial Pediatrics 135 2015 597 606
131. J Schmitt, L von Kobyletzki, A Svensson, C Apfelbacher Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials Br J Dermatol 164 2011 415 428
132. FM Garritsen, MW Brouwer, J Limpens, PI Spuls Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research Br J Dermatol 170 2014 501 513
133. E Roekevisch, PI Spuls, D Kuester, J Limpens, J Schmitt Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review J Allergy Clin Immunol 133 2014 429 438
134. J Schmitt, N Schmitt, M Meurer Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis J Eur Acad Dermatol Venereol 21 2007 606 619
135. IM Haeck, MJ Knol, O Ten Berge, SG van Velsen, MS de Bruin-Weller, CA Bruijnzeel-Koomen Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial J Am Acad Dermatol 64 2011 1074 1084
136. ME Schram, E Roekevisch, MM Leeflang, JD Bos, J Schmitt, PI Spuls A randomized trial of methotrexate versus azathioprine for severe atopic eczema J Allergy Clin Immunol 128 2011 353 359
137. NR Fuggle, W Bragoli, A Mahto, M Glover, AE Martinez, VA Kinsler The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring J Am Acad Dermatol 72 2015 108 114
138. MA El-Khalawany, H Hassan, D Shaaban, N Ghonaim, B Eassa Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt Eur J Pediatr 172 2013 351 356
139. FJ Bath-Hextall, AJ Birnie, JC Ravenscroft, HC Williams Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review Br J Dermatol 163 2010 12 26
140. JB Travers, A Kozman, Y Yao et al. Treatment outcomes of secondarily impetiginized pediatric atopic dermatitis lesions and the role of oral antibiotics Pediatr Dermatol 29 2012 289 296
141. BH Kaffenberger, J Mathis, MJ Zirwas A retrospective descriptive study of oral azole antifungal agents in patients with patch test-negative head and neck predominant atopic dermatitis J Am Acad Dermatol 71 2014 480 483
142. EJ van Zuuren, CJ Apfelbacher, Z Fedorowicz, A Jupiter, U Matterne, E Weisshaar No high level evidence to support the use of oral H1 antihistamines as monotherapy for eczema: a summary of a Cochrane systematic review Syst Rev 3 2014 25
143. RJ Boyle, FJ Bath-Hextall, J Leonardi-Bee, DF Murrell, ML Tang Probiotics for treating eczema Cochrane Database Syst Rev 4 2008 CD006135
144. FJ Bath-Hextall, C Jenkinson, R Humphreys, C Williams Hywel Dietary supplements for established atopic eczema Cochrane Database Syst Rev 2 2012 CD005205
145. J Reuter, I Merfort, CM Schempp Botanicals in dermatology: an evidence-based review Am J Clin Dermatol 11 2010 247 267
146. T Simonart, C Kabagabo, V De Maertelaer Homoeopathic remedies in dermatology: a systematic review of controlled clinical trials Br J Dermatol 165 2011 897 905
147. C Lopes, D Silva, L Delgado, O Correia, A Moreira Functional textiles for atopic dermatitis: a systematic review and meta-analysis Pediatr Allergy Immunol 24 2013 603 613
148. JM Bae, YY Choi, CO Park, KY Chung, KH Lee Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials J Allergy Clin Immunol 132 2013 110 117
149. A Otsuka, H Doi, G Egawa et al. Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression J Allergy Clin Immunol 133 2014 139 146 e10.
150. TE Stout, T McFarland, JC Mitchell, B Appukuttan, JT Stout Recombinant filaggrin is internalized and processed to correct filaggrin deficiency J Invest Dermatol 134 2014 423 429
151. LA Beck, D Thaçi, JD Hamilton et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis N Engl J Med 371 2014 130 139
152. EL Simpson, LE Keck, JR Chalmers, HC Williams How should an incident case of atopic dermatitis be defined? A systematic review of primary prevention studies J Allergy Clin Immunol 130 2012 137 144
153. M Foisy, RJ Boyle, JR Chalmers, EL Simpson, HC Williams The prevention of eczema in infants and children: an overview of Cochrane and non-Cochrane reviews Evid Based Child Health 6 2011 1322 1339
154. A Zutavern, I Brockow, B Schaaf the LISA Study Group Timing of solid food introduction in relation to eczema, asthma, allergic rhinitis, and food and inhalant sensitization at the age of 6 years: results from the prospective birth cohort study LISA Pediatrics 121 2008 e44 e52
155. EL Simpson, TM Berry, PA Brown, JM Hanifin A pilot study of emollient therapy for the primary prevention of atopic dermatitis J Am Acad Dermatol 63 2010 587 593
156. K Horimukai, K Morita, M Narita et al. Application of moisturizer to neonates prevents development of atopic dermatitis J Allergy Clin Immunol 134 2014 824 830 e6.
157. EL Simpson, JR Chalmers, JM Hanifin et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention J Allergy Clin Immunol 134 2014 818 823